Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

BACKGROUND: We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the addition of cetuximab to concurrent chemoradiation for patients with inoperable stage III non-small-cell lung cancer. METHODS: In this open-label randomis...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Lancet Oncol
Egile Nagusiak: Bradley, Jeffrey D, Paulus, Rebecca, Komaki, Ritsuko, Masters, Gregory, Blumenschein, George, Schild, Steven, Bogart, Jeffrey, Hu, Chen, Forster, Kenneth, Magliocco, Anthony, Kavadi, Vivek, Garces, Yolanda I, Narayan, Samir, Iyengar, Puneeth, Robinson, Cliff, Wynn, Raymond B, Koprowski, Christopher, Meng, Joanne, Beitler, Jonathan, Gaur, Rakesh, Curran, Walter, Choy, Hak
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4419359/
https://ncbi.nlm.nih.gov/pubmed/25601342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(14)71207-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak